Aidoc continuously monitors relevant medical exams and results across radiology, cardiology, and neurology to identify critical findings, triage patients, and coordinate care. Aidoc’s AI solutions are integrated into clinical workflows, enabling faster diagnosis and treatment with its FDA-cleared AI tools for patient management and care coordination.

The Blackford Platform is designed to simplify the integration, deployment, and management of AI applications for medical imaging. It hosts over 135 AI solutions, offering a centralized interface to manage multiple AI tools within existing healthcare infrastructures like PACS. The platform is fully DICOM-compliant and integrates with HL7 for data orchestration and reporting. It also features performance monitoring for tracking system health and AI activity in real-time.

CARPL provides a radiology AI platform that simplifies the integration, validation, and deployment of AI solutions within radiology departments. It offers access to over 110 AI applications from various vendors, enabling integration with existing PACS and RIS systems. The platform is designed to support scalable AI deployments, streamline workflows, and enhance diagnostic accuracy by providing a unified interface for managing AI solutions across different radiology tasks.

Cleerly is an AI-based digital care platform for the diagnosis of heart disease. It utilizes coronary computed tomography angiography (CCTA) to provide analyses of atherosclerosis, plaque buildup and stenosis, through machine learning algorithms. The technology creates 3D models of coronary arteries for early heart disease detection and treatment plans. It includes the Cleerly Proxy and Cleerly ISCHEMIA for coronary artery disease.

LumineticsCore by Digital Diagnostics is an AI diagnostic system that autonomously detects diabetic retinopathy, including macular edema, at the point-of-care using fundus images captured by a trained operator. It provides rapid results without needing specialist review, which facilitates immediate care decisions and referrals if disease is detected. The system is designed for healthcare providers, eye care professionals, payors, and patients, enhancing access to diagnostic evaluations for people with diabetes.

Envisionit Deep AI develops AI-driven radiology solutions, including RADIFY for automated image analysis and RATify for real-time AI model monitoring. Their tools are designed to assist radiologists with triaging and diagnostic support, particularly for critical conditions like pneumothorax and pleural effusion. The platform supports applications in teleradiology, training, and research, aiming to enhance diagnostic accuracy and accessibility.

Eon Patient Management (EPM) by Eon Health is a platform that uses Computational Linguistics to scan radiology reports and identify incidental findings with high accuracy and precision. It supports multiple disease-specific modules and integrates with hospital IT systems to streamline patient tracking and communication. EPM facilitates the scheduling of follow-up care, optimizes workflow by reducing manual tasks, and aims to improve patient outcomes by ensuring that necessary medical interventions are timely and effectively coordinated.

Expert AI provides a platform for healthcare professionals that includes real-time transcription and automated note generation, along with ICD-10 coding capabilities. The solution is aimed at streamlining documentation processes by capturing conversations and generating structured clinical notes. It also integrates with various healthcare systems, supporting improved efficiency and compliance. The platform is suitable for use in medical practice settings to aid in clinical documentation and coding accuracy.

Ligence offers AI-powered echocardiography analysis and reporting software called Ligence Heart. This platform automates the evaluation of heart ultrasound images, improving accuracy and efficiency in cardiac diagnostics. It integrates seamlessly with existing PACS and EHR systems, helping cardiologists streamline workflows, reduce reporting time, and enhance diagnostic precision. Ligence Heart supports various clinical guidelines and provides intuitive tools for accurate measurement and reporting.

Lunit is an AI software company developing advanced solutions for cancer diagnostics and therapeutics. Their products include Lunit INSIGHT CXR, which analyzes chest X-rays to detect abnormalities and Lunit INSIGHT MMG for breast cancer detection by reducing false positives. Lunit SCOPE IO and SCOPE PD-L1 enhance the precision of immunotherapy, analyzing cancer tissue samples to predict treatment response.

MEDICAL IP provides AI-powered solutions focused on medical image analysis, digital twin technology, and medical education. Its products include tools for whole-body composition analysis, lesion detection, surgical simulation, and 3D modeling. The platform leverages AI for precise image segmentation and generates digital twins used for training, patient consultation, and surgical planning.

Paige offers an AI-powered digital pathology platform designed to assist pathologists in diagnosing cancer and other diseases from pathology slides. The platform includes tools for detecting, quantifying, and visualizing tumor areas, providing decision support and streamlining workflows. Paige's AI models are trained on large datasets of pathology images and integrate with existing lab systems to enhance diagnostic accuracy and efficiency in clinical settings.

qMSK by Qure.ai is an AI-powered tool designed for analyzing musculoskeletal (MSK) X-rays. It assists in detecting and classifying fractures, dislocations, and other bone abnormalities. The tool supports radiologists by providing automated insights and prioritizing cases for review, particularly useful in emergency departments or high-volume settings. qMSK helps improve diagnostic accuracy and speeds up the decision-making process in MSK-related injuries.

Qure.ai develops AI-based healthcare solutions primarily for interpreting medical imaging, such as X-rays, CT scans, and MRIs. Their tools include qXR for detecting abnormalities in chest X-rays and qER for analyzing head CT scans for conditions like bleeds and fractures. The AI models are designed to support early diagnosis, expedite treatment pathways, and improve radiology workflows. Qure.ai's technology is used in clinical settings globally for applications in lung cancer screening, stroke management, and TB detection.

Rad AI Continuity helps automate radiology reporting and follow-up workflows. It integrates with PACS and RIS systems to generate radiologist impressions and manages patient follow-ups by tracking critical findings and ensuring that appropriate care is scheduled. This tool is used to improve radiology department efficiency, minimize missed follow-ups, and improve patient outcomes through better management of imaging results.

Rad AI Reporting is an AI-powered tool that automates the generation of radiology reports by analyzing imaging data and integrating it with PACS and RIS systems. It assists radiologists by automatically creating impressions based on findings, which can be edited before finalization. This helps reduce the time spent on report creation, ensuring consistent, high-quality output while allowing radiologists to focus on complex cases.

RapidAI develops AI-driven imaging solutions primarily for stroke, trauma, and vascular conditions. Its tools analyze brain scans, such as CT and MRI images, to assist physicians in diagnosing and treating conditions like stroke and subdural hematomas. The company's platform helps expedite treatment decisions by providing results within minutes, and it integrates into hospital systems via PACS and mobile apps. RapidAI has received FDA clearances for various modules, including those for detecting intracranial hemorrhages and subdural hematomas, making it a key tool in emergency neurovascular care.

Tempus Oncology is a precision medicine company that leverages AI and vast clinical and molecular data to support oncologists in making data-driven treatment decisions. Its offerings include comprehensive genomic profiling, minimal residual disease (MRD) testing, and AI-powered solutions like Tempus ONE, a voice-enabled device providing real-time access to patient data and clinical insights. The Tempus Next platform uses AI to optimize care pathways and close clinical gaps by analyzing EHR, imaging, and molecular data. Additionally, Tempus provides clinical trial matching and collaborates extensively with biopharma for drug discovery and research.

Viz.ai One is an AI-powered care coordination platform that helps healthcare teams detect and manage medical conditions like stroke, cardiovascular diseases, and trauma in real-time. It integrates with EHRs and PACS to streamline workflows and provides instant alerts for faster diagnosis and treatment. The platform supports communication across mobile and desktop devices for greater collaboration between multidisciplinary teams.